InsidersTradesSigma
Follow the 대한약품 stock price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 대한약품 has logged 140 reports. The latest transaction was reported on 31 August 2026 (Purchase). Among the most active insiders: 이윤우. The full history is accessible without an account.
140
Insider Decl.
n/a
Thresholds
€15,521
63 ops.
Buy Volume
n/a
2 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 31 August 2026
Declarations140 total
25 of 140 declarations
About 대한약품
대한약품 is a company in the health and pharmaceutical sector, listed on the XKRX market. It specializes in the manufacturing of pharmaceutical products and medications.